Your browser doesn't support javascript.
loading
Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood.
Rad Pour, Soudabeh; Pico de Coaña, Yago; Demorentin, Xavier Martinez; Melief, Jeroen; Thimma, Manjula; Wolodarski, Maria; Gomez-Cabrero, David; Hansson, Johan; Kiessling, Rolf; Tegner, Jesper.
Afiliação
  • Rad Pour S; Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Stockholm, Sweden soudabeh.radp@yahoo.com Jesper.tegner@kaust.edu.sa.
  • Pico de Coaña Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Demorentin XM; Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
  • Melief J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Thimma M; Biological and Environmental Sciences and Engineering Division (BESE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia.
  • Wolodarski M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Gomez-Cabrero D; Karolinska University Hospital, Stockholm, Sweden.
  • Hansson J; Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Stockholm, Sweden.
  • Kiessling R; Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
  • Tegner J; Biological and Environmental Sciences and Engineering Division (BESE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia.
J Immunother Cancer ; 9(5)2021 05.
Article em En | MEDLINE | ID: mdl-33963011

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Monócitos / Calgranulina B / Receptor de Morte Celular Programada 1 / Nivolumabe / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Monócitos / Calgranulina B / Receptor de Morte Celular Programada 1 / Nivolumabe / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article